Patents Assigned to GENOVUS BIOTECHNOLOGIES INC.
-
Patent number: 11793716Abstract: A device and method are provided for therapy and treatment of biological tissue such as muscle, tendon, and ligament tissue, by use of a device and method in which therapeutic vibrational frequency resonance patterns are transmitted to tissues of a patient. The resonance frequencies originate from many resonance domains, including vitamins, minerals, herbs, amino acids, and fatty acids. Each domain includes therapeutic frequency resonance patterns. These resonance patterns may be passively excited and transmitted to a patient to enhance tissue function, to decrease the normal rehabilitation time of damaged tissue, and provide therapeutic benefits for muscle tissue dysfunction. Therapeutic frequency resonance patterns may also be actively excited by a delivery mechanism that uses electromagnetic or mechanical waves to interact with the device. The actively excited device transmits the therapeutic frequency resonance patterns to the patients for similar enhancements and therapeutic benefits.Type: GrantFiled: December 20, 2021Date of Patent: October 24, 2023Assignee: Genovus Biotechnologies Inc.Inventors: Kimberly S. Gangwish, Garret Moddel
-
Patent number: 11633618Abstract: A system, device and method are provided for exposing a patient to therapeutic resonant frequency patterns (RFP) for therapy and treatment of a patient, for example, biological tissue such as muscle, tendon, ligament, and nerve tissue. The resonance frequencies originate from many bioactive substances, pharmaceuticals or other compounds, and key frequencies of the RFP of a compound can be replicated and then delivered to a patient using an electromagnetic catalyst to provide therapeutic benefits. RFPs can be imprinted in a separate device using a plasma imprinting device and method. This separate device can be actively excited by a delivery mechanism that uses electromagnetic or mechanical waves to interact with the device. The actively excited device transmits the RFPs or therapeutic resonant frequency patterns to the patient for similar enhancements and therapeutic benefits.Type: GrantFiled: December 22, 2020Date of Patent: April 25, 2023Assignee: Genovus Biotechnologies Inc.Inventors: Kimberly S. Gangwish, Garret Moddel, Casey Zahorik
-
Patent number: 11246799Abstract: A device and method are provided for therapy and treatment of biological tissue such as muscle, tendon, and ligament tissue, by use of a device and method in which therapeutic vibrational frequency resonance patterns are transmitted to tissues of a patient. The resonance frequencies originate from many resonance domains, including vitamins, minerals, herbs, amino acids, and fatty acids. Each domain includes therapeutic frequency resonance patterns. These resonance patterns may be passively excited and transmitted to a patient to enhance tissue function, to decrease the normal rehabilitation time of damaged tissue, and provide therapeutic benefits for muscle tissue dysfunction. Therapeutic frequency resonance patterns may also be actively excited by a delivery mechanism that uses electromagnetic or mechanical waves to interact with the device. The actively excited device transmits the therapeutic frequency resonance patterns to the patients for similar enhancements and therapeutic benefits.Type: GrantFiled: April 25, 2019Date of Patent: February 15, 2022Assignee: GENOVUS BIOTECHNOLOGIES INC.Inventors: Kimberly S. Gangwish, Garret Moddel
-
Patent number: 10888707Abstract: A system, device and method are provided for exposing a patient to therapeutic resonant frequency patterns (RFP) for therapy and treatment of a patient, for example, biological tissue such as muscle, tendon, ligament, and nerve tissue. The resonance frequencies originate from many bioactive substances, pharmaceuticals or other compounds, and key frequencies of the RFP of a compound can be replicated and then delivered to a patient using an electromagnetic catalyst to provide therapeutic benefits. RFPs can be imprinted in a separate device using a plasma imprinting device and method. This separate device can be actively excited by a delivery mechanism that uses electromagnetic or mechanical waves to interact with the device. The actively excited device transmits the RFPs or therapeutic resonant frequency patterns to the patient for similar enhancements and therapeutic benefits.Type: GrantFiled: September 19, 2016Date of Patent: January 12, 2021Assignee: GENOVUS BIOTECHNOLOGIES INC.Inventors: Kimberly S. Gangwish, Garret Moddel, Casey Zahorik
-
Patent number: 10322063Abstract: A device and method are provided for therapy and treatment of biological tissue such as muscle, tendon, and ligament tissue, by use of a device and method in which therapeutic vibrational frequency resonance patterns are transmitted to tissues of a patient. The resonance frequencies originate from many resonance domains, including vitamins, minerals, herbs, amino acids, and fatty acids. Each domain includes therapeutic frequency resonance patterns. These resonance patterns may be passively excited and transmitted to a patient to enhance tissue function, to decrease the normal rehabilitation time of damaged tissue, and provide therapeutic benefits for muscle tissue dysfunction. Therapeutic frequency resonance patterns may also be actively excited by a delivery mechanism that uses electromagnetic or mechanical waves to interact with the device. The actively excited device transmits the therapeutic frequency resonance patterns to the patients for similar enhancements and therapeutic benefits.Type: GrantFiled: September 18, 2014Date of Patent: June 18, 2019Assignee: GENOVUS BIOTECHNOLOGIES INC.Inventors: Kimberly S. Gangwish, Garret Moddel
-
Publication number: 20140288471Abstract: A device and method are provided for therapy and treatment of biological tissue such as muscle, tendon, and ligament tissue, by use of a device and method in which therapeutic vibrational frequency resonance patterns are transmitted to tissues of a patient. The resonance frequencies originate from many resonance domains, including vitamins, minerals, herbs, amino acids, and fatty acids. Each domain includes therapeutic frequency resonance patterns. These resonance patterns are identified, captured, and ultimately delivered to a mineral matrix component of the device. The combined resonance patterns are embedded in a mineral matrix that includes selected minerals and elements and is capable of retaining the combined or master frequency resonance patterns for a period of time. Resonance frequencies retained by the mineral matrix are transmitted to a patient to enhance tissue function, to decrease the normal rehabilitation time of a damaged tissue, and provide therapeutic benefits for muscle tissue dysfunction.Type: ApplicationFiled: March 19, 2014Publication date: September 25, 2014Applicant: GENOVUS BIOTECHNOLOGIES INC.Inventors: Kimberly S. Gangwish, Charles T. Krebs